Similar articles for PMID: 25667260

Year	Number of Results
1991	1
1992	4
1993	1
1994	2
1995	1
1996	2
1997	1
1999	4
2002	2
2003	3
2004	1
2005	3
2006	7
2007	5
2008	6
2009	11
2010	3
2011	4
2012	8
2013	9
2014	7
2015	4
2016	3
2017	6
2018	15
2019	5
2020	3
2021	4
2024	0

1

Intravenous immunoglobulin as clinical immune-modulating therapy.

Gilardin L, Bayry J, Kaveri SV. Gilardin L, et al. CMAJ. 2015 Mar 3;187(4):257-264. doi: 10.1503/cmaj.130375. Epub 2015 Feb 9. CMAJ. 2015. PMID: 25667260 Free PMC article. Review. No abstract available.

2

Immune supplementation and immune modulation with intravenous immunoglobulin.

Mazer BD, Al-Tamemi S, Yu JW, Hamid Q. Mazer BD, et al. J Allergy Clin Immunol. 2005 Oct;116(4):941-4. doi: 10.1016/j.jaci.2005.07.021. J Allergy Clin Immunol. 2005. PMID: 16210080 No abstract available.

3

Intravenous immunoglobulins for rituximab-resistant mucous membrane pemphigoid.

Witte M, Zillikens D, Shimanovich I. Witte M, et al. J Eur Acad Dermatol Venereol. 2018 Aug;32(8):e321-e324. doi: 10.1111/jdv.14873. Epub 2018 Mar 6. J Eur Acad Dermatol Venereol. 2018. PMID: 29443427 No abstract available.

4

ASHP therapeutic guidelines for intravenous immune globulin. ASHP Commission on Therapeutics.

[No authors listed] [No authors listed] Clin Pharm. 1992 Feb;11(2):117-36. Clin Pharm. 1992. PMID: 1312920 Review. No abstract available.

5

Resistance to intravenous immunoglobulin (IVIG) in Kawasaki disease: no influence of different IVIG lot utilisation.

Pagnini I, Marino A, Simonini G, Cimaz R. Pagnini I, et al. Clin Exp Rheumatol. 2012 Jan-Feb;30(1 Suppl 70):S170. Epub 2012 May 11. Clin Exp Rheumatol. 2012. PMID: 22410254 No abstract available.

6

Immunoglobulin for concurrent Guillain-Barré and immune thrombocytopenic purpura.

Zeidman LA, Fahey CD, Grinblatt DL, Harsanyi K. Zeidman LA, et al. Pediatr Neurol. 2006 Jan;34(1):60-2. doi: 10.1016/j.pediatrneurol.2005.06.012. Pediatr Neurol. 2006. PMID: 16376282

7

[Immunoglobulin in suspected Kawasaki disease].

García Soblechero E, Gómez Santos E, Domínguez Quintero ML, González Vila L. García Soblechero E, et al. An Pediatr (Barc). 2010 Sep;73(3):151-2. doi: 10.1016/j.anpedi.2010.05.015. Epub 2010 Jul 4. An Pediatr (Barc). 2010. PMID: 20605119 Free article. Spanish. No abstract available.

8

Intravenous immunoglobulin therapy for refractory ocular cicatricial pemphigoid: case report.

Galdos M, Etxebarría J. Galdos M, et al. Cornea. 2008 Sep;27(8):967-9. doi: 10.1097/ICO.0b013e318172fbc5. Cornea. 2008. PMID: 18724167

9

External validation of a scoring system to predict resistance to intravenous immunoglobulin.

Kobayashi T, Inoue Y, Tamura K, Morikawa A, Kobayashi T. Kobayashi T, et al. J Pediatr. 2007 Apr;150(4):e37; author reply e38. doi: 10.1016/j.jpeds.2006.12.036. J Pediatr. 2007. PMID: 17382098 No abstract available.

10

A case of anti-BP180 type mucous membrane pemphigoid treated with intravenous immunoglobulin.

Aoki N, Nakajima K, Shiga T, Koga H, Hashimoto T, Sano S. Aoki N, et al. J Dermatol. 2014 Jun;41(6):557-9. doi: 10.1111/1346-8138.12502. J Dermatol. 2014. PMID: 24909219 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

112 results

Results by year